MarshallALevineMD

Oncology • Baltimore, MD

Physician

Join to view full profile

Dr. Levine is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Levine's full profile

Already have an account?

Office
6569 N Charles St
Suite 201
Baltimore, MD 21204
Phone+1 443-849-3051

Fax+1 443-849-3057

Education & Training

Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1975 - 1976
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1972 - 1975
Beth Israel Deaconess Medical CenterResidency, Surgery, 1970 - 1972
University of Colorado School of Medicine Anschutz Medical CampusClass of 1970

Certifications & Licensure

MD State Medical License 1975 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Fellow (FACP) American College of Physicians, 2001

Clinical Trials

Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate
Unknown status
Phase 3
Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone
Unknown status
Phase 3
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer Start of enrollment: 2014 Jan 22
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305.
Athanassios Argiris, Yael Flamand, Panayiotis Savvides, Jennifer M Johnson, Ioannis Vathiotis
European Journal of Cancer. 2024-03-01
62 citations
Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer.
Athanassios Argiris, Shuli Li, Panayiotis Savvides, James Ohr, Jill Gilbert
Journal of Clinical Oncology. 2019-10-16
2 citations
Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma.
Joseph A. Califano, Zubair Khan, Kimberly A. Noonan, Lakshmi Rudraraju, Zhe Zhang
Clinical Cancer Research. 2018-12-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American College of Physicians - ACP
Fellow